• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2017 Fiscal Year Final Research Report

A possibility of MAPK signaling as a target of combination therapy with HDAC inhibitor

Research Project

  • PDF
Project/Area Number 16K19732
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Dermatology
Research InstitutionKagoshima University

Principal Investigator

IBUSUKI Atsuko  鹿児島大学, 医歯学域医学系, 助教 (10596109)

Project Period (FY) 2016-04-01 – 2018-03-31
Keywords皮膚リンパ腫 / HDAC阻害剤 / MAPK
Outline of Final Research Achievements

I performed the exhaustive protein tyrosine kinase assay of 3 CTCL cell lines (Hut78, HH and MJ) with 3 HDACi (romidepsin, vorinostat and belinostat) by Pamchip and found that all tested HDACi upregulated phosphorylation activity of MAPK1/ERK2 in Hut78. Furthermore, inhibitors of MEK, an upstream kinase of MAPK1, significantly enhanced the anti-proliferative effect of HDACi in Hut78.

Free Research Field

皮膚科学

URL: 

Published: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi